ScreenerHero

EAH ECO Animal Health Group plc

LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · ecoanimalhealth.com
97.00GBp-1.02%Mkt Cap: 70.35M $P/E: 32.33

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respirat…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap70.35M USD
Enterprise Value59.04M USD
Revenue (TTM)95.14M USD
Gross Profit46.19M USD
Net Income (TTM)2.38M USD
Revenue/Share1.30 GBp
Last Price97.00 GBp
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees213
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINLU2356220926
Valuation
P/E (Trailing)32.33
P/E (Forward)20.59
PEG—
EV/EBITDA7.04
EV/Revenue0.62
P/S0.75
P/B0.76
EPS (TTM)0.03
EPS (Forward)0.05
52W Range
0.000083% of range116.90
52W High116.90 GBp
52W Low0.0000 GBp
Profitability
Gross Margin48.55%
Oper. Margin9.46%
EBITDA Margin8.82%
Profit Margin2.50%
ROE2.51%
ROA1.85%
Growth
Revenue Growth3.70%
Earnings Growth-24.50%
Cash Flow & Leverage
Operating CF8.32M USD
CapEx (TTM)4.11M USD
FCF Margin6.10%
FCF Yield8.24%
Net Debt-22.28M USD
Net Debt/EBITDA-2.66
Balance Sheet
Debt/Equity0.06
Current Ratio3.42
Quick Ratio2.63
Book Value/Sh1.28 GBp
Cash/Share0.38 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield1.36%
Payout Ratio0.00%
Ex-Div DateSep 23, 2021
Pay Date—
Splits
Last Split3:1
Split DateOct 18, 2002
Analyst Consensus
Rating—
Target (Mean)202.00 GBp
Upside (mean)+108.2%
Target Range165.00 GBp – 273.00 GBp
165.00+108.2% to mean273.00
# Analysts5
Ownership
Shares Out.66.73M
Float59.27M
Insiders16.37%
Institutions66.78%
Technical
SMA 5098.67 (-1.7%)
SMA 20098.13 (-1.2%)
Beta0.00
S&P 52W Chg14.58%
Avg Vol (30d)156.25K
Avg Vol (10d)132.36K
Technical Indicators
RSI (14)52.8
MACD0.7517
MACD Signal1.1391
MACD Hist.-0.3874
BB Upper102.51 GBp
BB Middle98.63 GBp
BB Lower94.75 GBp
BB Width7.87%
ATR (14)3.197 GBp
Vol Ratio (20d)0.24x